We'd like your feedback
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.
Natalie
Byrne
cuh.poppy@nhs.net
Dr
ian
wilkinson
ibw20@cam.ac.uk
More information about this study, what is involved and how to take part can be found on the study website.
Disorders related to length of gestation and fetal growthIschaemic heart diseasesDiabetes mellitusOedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium
This information is provided directly by researchers, and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information. In some summaries, you may come across links to external websites. These websites will have more information to help you better understand the study.
The study primary aim is to determine if pregnancy complications have a negative effect on the health of women following their pregnancy, which cannot be accounted for by any factors which were present prior to pregnancy.
Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.
The recruitment start and end dates are as follows:
Observational type: Cohort study;
You can take part if:
You may not be able to take part if:
Pregnancy study arm - Exclusion criteria • Currently pregnant • Established infertility • Planning or actively using fertility treatments (e.g. IVF, ICSI, FET, IUI) • Assigned male sex at birth • Autoimmune disease (e.g. rheumatoid arthritis, lupus) • Thrombophilia • Type 1 diabetes • Known advanced chronic kidney disease (stages 4-5) • Malignant hypertension • Clinically manifest CVD (e.g. previous myocardial infarction, stroke) • Active cancer/being treated for cancer currently (other than skin cancer) • Any other condition preventing full participation in the study Non-Pregnancy study arm - Exclusion criteria • Currently pregnant • Planning or actively using fertility treatments (e.g. IVF, ICSI, FET, IUI) • Assigned male sex at birth • Autoimmune disease (e.g. rheumatoid arthritis, lupus) • Thrombophilia • Type 1 diabetes • Known advanced chronic kidney disease (stages 4-5) • Malignant hypertension • Clinically manifest CVD (e.g. previous myocardial infarction, stroke) • Active cancer/being treated for cancer currently (other than skin cancer) • Any other condition preventing full participation in the study
Below are the locations for where you can take part in the trial. Please note that not all sites may be open.
Dr
ian
wilkinson
ibw20@cam.ac.uk
Natalie
Byrne
cuh.poppy@nhs.net
More information about this study, what is involved and how to take part can be found on the study website.
The study is sponsored by CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST and funded by Wellcome Trust .
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Read full details
for Trial ID: CPMS 54811
You can print or share the study information with your GP/healthcare provider or contact the research team directly.
